Association Between Blood Heavy Metal Levels and Predicted 10-Year Risk for A First Atherosclerosis Cardiovascular Disease in the General Korean Population by 장성인




Association between Blood Heavy Metal Levels and
Predicted 10-Year Risk for A First Atherosclerosis
Cardiovascular Disease in the General
Korean Population
Sungchul Choi 1,†, Junhyun Kwon 2,3,†, Pyohyeok Kwon 1, Changyoon Lee 1 and
Sung-In Jang 3,4,*
1 Department of Medicine, Yonsei University College of Medicine, Seoul 03722, Korea;
sungchulc@yonsei.ac.kr (S.C.); kkph01@yonsei.ac.kr (P.K.); yoonvly25@yonsei.ac.kr (C.L.)
2 Department of Public Health, Graduate School, Yonsei University, Seoul 03722, Korea; judekwon@yuhs.ac
3 Institute of Health Services Research, Yonsei University, Seoul 03722, Korea
4 Department of Preventive Medicine, Yonsei University College of Medicine, Seoul 03722, Korea
* Correspondence: jangsi@yuhs.ac; Tel.: +82-2-2228-1863; Fax: +82-2-392-8133
† These authors contributed equally to this work.
Received: 5 March 2020; Accepted: 19 March 2020; Published: 23 March 2020


Abstract: Background: Atherosclerotic cardiovascular disease (ASCVD) is a preventable type of
disease, thus, specifying factors that increase the occurrence of this type of disease is needed. Heavy
metals such as cadmium (Cd), lead (Pb), and mercury (Hg) have been suggested as possible factors
influencing the development of cardiovascular disease. We aimed to link blood heavy metal levels
(Cd, Pb, Hg) with 10-year ASCVD risk scores. Methods: A population of 993 men and 1431 women
who participated in the Korea National Health and Nutrition Examination Survey (KNHANES) were
included. The 2013 American College of Cardiology/American Heart Association (ACC/AHA) pooled
cohort equations risk prediction model and Korean Risk Prediction Model (KRPM) were used as
means for risk prediction. Following multivariate adjustment; blood Cd; Pb; and Hg levels were
divided into quartiles for analysis using linear trends estimation and multiple regression models.
Results: There was an overall positive trend between blood Cd, Pb, and Hg levels and 10-year ASCVD
risk scores; KRPM risk score increasing by quartile for blood Cd (men p < 0.0001, women p = 0.0024),
Pb (men p = 0.0097, women p = 0.0330), Hg (men p = 0.0096, women p = 0.0030) rates and pooled
cohort equations risk score increasing by quartile for Cd (men p < 0.0001, women p = 0.0034) and
Hg (men p = 0.0099, women p = 0.0010) with linear trends. Urban population showed a stronger
relationship between blood Cd, Pb, and Hg levels and 10-year ASCVD risk score especially among
men with multiple regression analysis. Conclusion: Blood Cd, Pb, and Hg levels are associated with
ASCVD risk. Thus, they should be considered while developing preventive measures for ASCVD.
Keywords: blood cadmium levels; blood lead levels; blood mercury levels; 10-year ASCVD risk
1. Introduction
Atherosclerotic cardiovascular disease (ASCVD), which includes nonfatal myocardial infarction,
coronary heart disease (CHD) death, and fatal or nonfatal stroke [1], takes up a large proportion of
healthcare budgets worldwide [2,3]. In addition to the extensive healthcare expenditures incurred,
it is one of the leading causes of death [2,3]. This trend of severity is also true for the South Korean
population, where the number of cardiovascular disease patients is high, with one in five deaths
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occurring due to cardiovascular reasons [4]. Therefore, considering its financial and social burdens,
it is critical to estimate the risk of ASCVD and to prevent related risk factors with early measures.
The 10-year ASCVD risk score in the 2013 ACC/AHA Guideline on the Assessment of
Cardiovascular Risk is a widely used, reliable estimator of predicted 10-year risk for a first ASCVD
event that uses the pooled cohort equation [1]. Individual risk is calculated based on current health
status, age, total cholesterol, HDL cholesterol, hypertension treatment, smoking status, and diabetes; in
so doing, early initiation of primary prevention can be implemented [5]. This 10-year ASCVD risk score
has been reported to have advantages when used in a primary care setting for untreated populations
among the Asian population [6]. However, because the 2013 ACC/AHA Guideline on the Assessment
of Cardiovascular Risk was created within a specific pool, namely non-Hispanic African-American
and non-Hispanic white in the US, numerous studies have reported that this 10-year ASCVD risk
score overestimates the risk of ASCVD in Asian populations [6–8]. Because of the non-generalizability
of this risk score, there have been efforts to create a new pooled cohort equations to fit the Korean
population by adjusting the 2013 ACC/AHA pooled cohort equations [7]. The Korean Risk Prediction
Model (KRPM) for ASCVD risk was developed as a calibrated version of the 10-year ASCVD risk score
for the Korean population, and this novel risk score has been reported to accurately measure the risk of
ASCVD among the Korean population [7].
Numerous risk factors have been reported to increase the ASCVD risk or to be associated with
increasing the ASCVD risk; among these factors are blood heavy metal levels. Xenobiotic blood heavy
metals such as cadmium (Cd), lead (Pb), and mercury (Hg), have been linked with atherosclerotic
disease [9]. In particular, Cd and Pb were found to affect aortic atherosclerosis in animal studies [10,11].
There is evidence suggesting that these heavy metals inactivate several enzymes, antioxidants, and
amino acids with high affinities for sulfhydryl groups [12], thus possibly having potential to affect
atherosclerotic cardiovascular diseases (ASCVD). Emerging evidences are also pointing at the correlative
link between heavy metal levels and ASCVD; Cd levels being associated with myocardial infarction
and other cardiovascular diseases [13,14], suggestive evidence mounting that support the association
between Pb exposure and clinical cardiovascular outcomes [15], Hg having overall vascular effects
including oxidative stress, inflammation, and endothelial dysfunction [16], which often is linked with
ASCVD [17–19]. Taken together, the evidence suggests a need for further scrutiny of the relationship
between blood heavy metal levels and ASCVD risk. Therefore, in this study, we investigated the
association of blood heavy metal levels of Cd, Pb, and Hg with 10-year ASCVD risk score according to
the KRPM with a cross-sectional approach using data from KNHANES.
2. Methods
2.1. Study Population
Data from the KNHANES, conducted by the Korean Centers for Disease Control and Prevention to
evaluate the health and nutritional status of the Korean population, were used for this study. This survey
is a national, cross-sectional, population-based survey that assesses the health and nutritional status of
the Korean population using health interviews and examinations and nutrition surveys. The nationally
representative KNHANES includes approximately 10,000 non-institutionalized civilians as its sample
every year [20] and is a reliable dataset which is multi-stage stratified based on 16 metropolitan cities
and provinces, as well as administrative divisions and dwelling units. Also, sex, age, residential area
ratio, and householder’s education level were used as implicit stratification variables to make the
data more representative of the population. Further information about the dataset is available on the
website [21] (http://knhanes.cdc.go.kr).
The KNHANES baseline datasets included 8127 and 8150 individuals in 2016 and 2017, respectively.
Both 10-year ASCVD risk score used in this study is only applicable to those in the age range of 40 to
80, thus only those in this particular age range was selected as eligible participants (8651 participants).
Also, the KNHANES selected one third of its sample for blood heavy metal (Cd, Pb, Hg) levels testing
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with sub-sampling methods using double-sampling, leaving 3265 participants when exclusion was
done from participants within the age range of 40 to 80. Thus, the exclusion criteria were age < 40 years,
age > 80 years, participants not tested for blood heavy metal (Cd, Pb, Hg) levels, and missing data for
variables. After exclusion of ineligible participants, 2424 participants, including 993 men and 1431
women, were included in this study. KNHANES survey data for years 2016 and 2017 was exempt
from obtaining approval from the Institutional Review Board since the survey was conducted directly
by the government of South Korea for public welfare (Bioethics and Safety Act. Republic of Korea).
The present study thus did not require additional Institutional Review Board approval because the
KNHANES data are publicly available.
2.2. Measures
2.2.1. Dependent Variable
This study aimed to investigate the differences in 10-year ASCVD risk score using risk scores
from the KRPM for ASCVD and the 2013 ACC/AHA Guideline on the Assessment of Cardiovascular
Risk. The 10-year ASCVD risk score is a simple means of assessing the risk of developing a first
ASCVD event, including nonfatal myocardial infarction, CHD death, and fatal or nonfatal stroke, over
the course of 10 years in a person without any history of nonfatal myocardial infarction (recognized
or unrecognized), stroke, heart failure, percutaneous coronary intervention, coronary artery bypass
surgery, or atrial fibrillation [1]. The 10-year ASCVD risk score was measured using the equation
from the KRPM for ASCVD. The original 10-year ASCVD risk score by 2013 ACC/AHA Guideline
on the Assessment of Cardiovascular Risk was also used to supplement these findings. Following
the AHA’s recommendation that the equations for non-Hispanic Whites should be used for ethnic
groups other than African-Americans, the ASCVD risk score equation for non-Hispanic Whites was
used to determine the risk of the target population (Supplementary Tables S1–S3, At the bottom of the
article). Both risk scores measure the probability of developing a first ASCVD event in 10 years and are
represented as percentages (%) from 0% to 100% as shown in Table 1 and Supplementary Table S1.
The 10-year ASCVD risk score was log-adjusted in Tables 2 and 3 and Supplementary Tables S2 and S3
to meet the requirement of residual normality for accurate linear regression analysis.




b Risk Score (%)
(KRPM c)
Subjects ASCVD
b Risk Score (%)
(KRPM c)
N % Mean ± SD p-Value * N % Mean ± SD p-Value *
Total 993 11.19 9.99 1431 5.49 6.10
Quartile Cd <0.0001 <0.0001
25% 250 25 8.67 9.76 359 25 4.30 5.81
50% 249 25 10.75 9.39 357 25 5.42 6.02
75% 246 25 11.85 9.80 357 25 5.66 5.66
100% 248 25 13.51 10.39 358 25 6.60 6.67
Quartile Pb 0.0008 <0.0001
25% 249 25 9.40 9.75 358 25 4.28 5.62
50% 248 25 10.67 10.04 358 25 5.47 6.41
75% 248 25 11.85 9.73 358 25 5.40 5.56
100% 248 25 12.84 10.13 357 25 6.82 6.53





b Risk Score (%)
(KRPM c)
Subjects ASCVD
b Risk Score (%)
(KRPM c)
N % Mean ± SD p-Value * N % Mean ± SD p-Value *
Quartile Hg <0.0001 0.0387
25% 249 25 13.96 11.76 360 25 5.59 6.25
50% 248 25 10.08 9.40 356 25 6.00 6.94
75% 248 25 9.80 8.37 359 25 4.73 5.06
100% 248 25 10.90 9.60 356 25 5.66 5.98
Age <0.0001 <0.0001
40–49 280 28 2.93 1.94 439 31 1.19 0.66
50–59 277 28 6.65 3.80 443 31 2.93 1.51
60–69 243 24 13.37 5.31 340 24 7.35 3.34
70–79 193 19 26.93 8.32 209 15 16.94 6.46
Income status 0.5946 0.9414
Low 241 24 11.36 9.86 344 24 5.59 6.06
Mid-low 247 25 11.55 10.84 362 25 5.34 5.86
Mid-high 239 24 10.42 9.21 339 24 5.58 6.27
High 266 27 11.39 9.97 386 27 5.48 6.24
Job <0.0001 <0.0001
White Collar 261 26 5.37 5.31 237 17 1.83 1.82
Pink Collar 74 7 8.10 6.84 241 17 3.48 3.67
Blue Collar 406 41 11.21 9.55 308 22 6.11 6.05
Unemployed 252 25 18.09 10.87 645 45 7.30 7.01
Area <0.0001 0.0003
Urban 773 78 10.37 9.32 1147 80 5.21 5.90
Rural 220 22 14.07 11.61 284 20 6.65 6.77
Sleep 0.0025 0.0237
Under 7 h 388 39 9.99 9.07 610 43 5.92 6.64
Over 7 h 605 61 11.96 10.46 821 57 5.18 5.66
Physical Activity <0.0001 <0.0001
No activity 149 15 14.11 11.13 227 16 7.23 7.31
Walking 423 43 11.65 10.29 778 54 5.72 6.09
MVPA a 47 5 12.05 12.29 35 2 7.90 7.99
Walking+MVPA 374 38 9.40 8.40 391 27 3.81 4.57
* ANOVA (one-way) was performed independently for each variable. a MVPA: Moderate to vigorous physical
activity which includes vigorous intensity, moderate intensity, and strength-related physical activities b ASCVD:
Atherosclerotic cardiovascular diseases; c KRPM: Korean risk prediction model.
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Table 2. Results of analyzing the effect of the blood heavy metal quartile.
Variables




** S.E p-Value β
eˆβ
** S.E p-Value B
eˆβ
** S.E p-Value β
eˆβ
** S.E p-Value β
eˆβ
** S.E p-Value β
eˆβ
** S.E p-Value
Quartile Cd <0.0001 * 0.0024 *
25% Ref. - - - - - - - - Ref. - - - - - - - -
50% 0.132 1.141 0.048 0.006 - - - - - - - - 0.023 1.023 0.041 0.572 - - - - - - - -
75% 0.163 1.177 0.053 0.002 - - - - - - - - −0.009 0.991 0.037 0.802 - - - - - - - -
100% 0.269 1.309 0.059 <0.0001 - - - - - - - - 0.102 1.108 0.039 0.010 - - - - - - - -
Quartile Pb 0.0097 * 0.0330 *
25% - - - - Ref. - - - - - - - - Ref. - - - -
50% - - - - −0.008 0.992 0.057 0.888 - - - - - - - - 0.036 1.037 0.041 0.381 - - - -
75% - - - - 0.081 1.084 0.055 0.143 - - - - - - - - 0.014 1.015 0.038 0.703 - - - -
100% - - - - 0.117 1.124 0.057 0.041 - - - - - - - - 0.072 1.075 0.039 0.062 - - - -
Quartile Hg 0.0096 * 0.0030 *
25% - - - - - - - - Ref. - - - - - - - - Ref.
50% - - - - - - - - 0.031 1.032 0.053 0.560 - - - - - - - - 0.024 1.025 0.038 0.525
75% - - - - - - - - 0.103 1.109 0.060 0.085 - - - - - - - - 0.056 1.057 0.043 0.194
100% - - - - - - - - 0.126 1.135 0.060 0.037 - - - - - - - - 0.112 1.118 0.039 0.005
Age
40–49 Ref. Ref. Ref. Ref. Ref. Ref.
50–59 0.768 2.155 0.054 <0.0001 0.790 2.203 0.056 <0.0001 0.800 2.225 0.055 <0.0001 0.839 2.314 0.035 <0.0001 0.834 2.301 0.035 <0.0001 0.841 2.319 0.035 <0.0001
60–69 1.532 4.629 0.053 <0.0001 1.548 4.704 0.053 <0.0001 1.557 4.746 0.052 <0.0001 1.801 6.055 0.039 <0.0001 1.800 6.052 0.040 <0.0001 1.808 6.097 0.039 <0.0001
70–79 2.199 9.016 0.052 <0.0001 2.218 9.190 0.050 <0.0001 2.251 9.495 0.051 <0.0001 2.594 13.388 0.042 <0.0001 2.597 13.424 0.041 <0.0001 2.612 13.625 0.041 <0.0001
Income status
Low Ref. Ref. Ref. Ref. Ref. Ref.
Mid-low −0.039 0.961 0.056 0.484 −0.044 0.957 0.058 0.451 −0.043 0.958 0.057 0.454 −0.065 0.937 0.045 0.149 −0.067 0.935 0.044 0.131 −0.070 0.932 0.044 0.113
Mid-high −0.061 0.941 0.064 0.344 −0.080 0.923 0.063 0.204 −0.077 0.926 0.064 0.228 −0.121 0.886 0.044 0.007 −0.119 0.887 0.044 0.007 −0.124 0.883 0.044 0.005
High 0.003 1.004 0.054 0.948 −0.013 0.987 0.053 0.808 −0.043 0.958 0.055 0.429 −0.065 0.937 0.046 0.153 −0.066 0.936 0.046 0.151 −0.078 0.925 0.045 0.084
Job
White Collar Ref. Ref. Ref. Ref. Ref. Ref.
Pink Collar 0.146 1.157 0.076 0.055 0.151 1.163 0.081 0.062 0.161 1.174 0.079 0.042 0.086 1.090 0.052 0.097 0.085 1.089 0.052 0.106 0.084 1.087 0.052 0.108
Blue Collar 0.104 1.110 0.053 0.049 0.098 1.103 0.054 0.071 0.124 1.132 0.055 0.023 0.093 1.097 0.051 0.072 0.085 1.089 0.051 0.096 0.090 1.095 0.051 0.079
Unemployed 0.159 1.173 0.057 0.006 0.181 1.198 0.059 0.002 0.200 1.222 0.057 0.001 0.094 1.098 0.042 0.025 0.086 1.090 0.042 0.039 0.094 1.098 0.041 0.022
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Table 2. Cont.
Variables




** S.E p-Value β
eˆβ
** S.E p-Value B
eˆβ
** S.E p-Value β
eˆβ
** S.E p-Value β
eˆβ




Rural Ref. Ref. Ref. Ref. Ref. Ref.
Urban −0.021 0.979 0.043 0.623 −0.015 0.985 0.042 0.724 −0.019 0.981 0.042 0.642 −0.053 0.949 0.040 0.183 −0.053 0.949 0.038 0.173 −0.049 0.952 0.038 0.201
Sleep
Under 7 h Ref. Ref. Ref. Ref. Ref. Ref.
Over 7 h −0.033 0.968 0.039 0.406 −0.031 0.970 0.039 0.437 −0.045 0.956 0.040 0.267 −0.055 0.946 0.029 0.058 −0.056 0.945 0.030 0.058 −0.064 0.938 0.029 0.027
Physical
Activity
No activity Ref. Ref. Ref. Ref. Ref. Ref.
Walking −0.044 0.957 0.060 0.469 −0.063 0.939 0.059 0.285 −0.056 0.946 0.060 0.350 −0.111 0.895 0.036 0.002 −0.114 0.892 0.036 0.002 −0.117 0.889 0.036 0.001
MVPA a −0.038 0.963 0.104 0.720 −0.075 0.927 0.107 0.481 −0.082 0.921 0.110 0.455 −0.106 0.900 0.084 0.212 −0.099 0.906 0.085 0.245 −0.115 0.891 0.083 0.166
Walking+MVPA −0.157 0.854 0.066 0.017 −0.191 0.826 0.065 0.003 −0.193 0.824 0.066 0.004 −0.147 0.863 0.042 0.001 −0.151 0.860 0.042 0.0004 −0.159 0.853 0.042 0.0002
Multiple regression analysis and linear trend results are shown. * p-value for linear trend ** eˆβ shows a percental increase of 10-year ASCVD risk score compared with the reference criteria.
a MVPA: Moderate to vigorous physical activity which includes vigorous intensity, moderate intensity, and strength-related physical activities b ASCVD: Atherosclerotic cardiovascular
diseases c KRPM: Korean risk prediction model.
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Table 3. Subgroup analysis of the effect of the blood heavy metal quartile.
Variables
ASCVD a Risk Score (Log-Transformed KRPM b)
Location of Residence Sleep Duration
Urban Rural Under 7 h Over 7 h
β eˆβ * S.E p-Value β eˆβ S.E p-Value β eˆβ S.E p-value β eˆβ S.E p-Value
Men
Quartile Cd
25% ref. ref. ref. ref.
50% 0.161 1.175 0.054 0.003 −0.094 0.910 0.101 0.353 0.117 1.124 0.058 0.045 0.151 1.163 0.089 0.090
75% 0.188 1.207 0.058 0.001 −0.014 0.987 0.107 0.900 0.158 1.171 0.068 0.022 0.196 1.216 0.076 0.011
100% 0.270 1.310 0.066 <0.0001 0.155 1.168 0.115 0.180 0.232 1.261 0.070 0.001 0.310 1.363 0.088 0.001
Quartile Pb
25% ref. ref. ref. ref.
50% −0.001 0.999 0.064 0.989 0.051 1.053 0.132 0.697 0.010 1.010 0.074 0.897 −0.015 0.985 0.093 0.873
75% 0.082 1.085 0.057 0.154 0.134 1.143 0.152 0.378 0.029 1.029 0.075 0.702 0.145 1.156 0.081 0.074
100% 0.133 1.142 0.062 0.032 0.079 1.082 0.119 0.509 0.097 1.102 0.066 0.141 0.183 1.201 0.094 0.053
Quartile Hg
25% ref. ref. ref. ref.
50% 0.043 1.044 0.058 0.457 −0.088 0.916 0.100 0.380 0.095 1.100 0.075 0.202 −0.047 0.954 0.082 0.566
75% 0.095 1.100 0.066 0.152 0.053 1.054 0.115 0.645 0.159 1.173 0.070 0.023 0.010 1.010 0.094 0.919
100% 0.130 1.139 0.066 0.049 0.028 1.028 0.112 0.803 0.143 1.153 0.074 0.055 0.093 1.097 0.090 0.306
Women
Quartile Cd
25% ref. ref. ref. ref.
50% 0.071 1.074 0.042 0.094 −0.253 0.776 0.100 0.012 0.079 1.082 0.052 0.127 −0.055 0.946 0.065 0.398
75% −0.005 0.995 0.040 0.902 −0.006 0.994 0.081 0.937 0.027 1.027 0.047 0.565 −0.074 0.929 0.061 0.226
100% 0.114 1.121 0.042 0.007 0.051 1.053 0.096 0.591 0.102 1.107 0.055 0.066 0.091 1.095 0.055 0.101
Quartile Pb
25% ref. ref. ref. ref.
50% 0.033 1.033 0.046 0.475 −0.001 0.999 0.078 0.986 0.076 1.079 0.050 0.130 −0.020 0.981 0.060 0.744
75% 0.007 1.007 0.042 0.875 0.003 1.003 0.088 0.976 0.078 1.081 0.047 0.096 −0.068 0.935 0.060 0.259
100% 0.038 1.039 0.043 0.377 0.212 1.236 0.085 0.013 0.110 1.116 0.048 0.023 0.021 1.021 0.059 0.719
Quartile Hg
25% ref. ref. ref. ref.
50% 0.026 1.026 0.043 0.551 0.022 1.023 0.069 0.745 0.053 1.055 0.050 0.286 −0.002 0.998 0.058 0.967
75% 0.050 1.051 0.046 0.284 0.103 1.109 0.109 0.342 0.067 1.069 0.052 0.203 0.049 1.050 0.066 0.455
100% 0.113 1.120 0.043 0.009 0.120 1.128 0.089 0.177 0.116 1.123 0.052 0.027 0.110 1.117 0.065 0.090
Mltiple regression analysis results are shown. * eˆβ shows a percental increase of 10-year ASCVD risk score compared with the reference criteria. a ASCVD: Atherosclerotic cardiovascular
diseases. b KRPM: Korean risk prediction model
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2.2.2. Variables of Interest
Blood heavy metal levels were the variables of interest. Blood cadmium (Cd), lead (Pb), and
mercury (Hg) levels were measured during the KNHANES 2016 and 2017. Blood Cd and Pb levels
were measured using the graphite furnace atomic absorption method on a PerkinElmer AAnalyst
AAS-600 (PerkinElmer, Turku, Finland) whereas blood Hg levels were measured using the gold
mercury amalgamation method on a DMA-80 (Milestone, Italy). The entire population was divided
into four quartiles depending on the blood heavy metal levels: 0%–25%, 25%–50%, 50%–75%, and
75%–100% for each heavy metal.
2.2.3. Covariates
Stratification based on sex was included because the 2013 ACC/AHA Guideline on the Assessment
of Cardiovascular Risk has different calculations depending on sex. This study also included age
(40–49, 50–59, 60–69, and 70–79 years), income status (low, mid-low, mid-high, and high), job type
(white collar, pink collar, blue collar, and unemployed), area of living (rural or urban area), amount of
sleep (≥7 h and <7 h), physical activity per week (no activity, walking, moderate-to-vigorous physical
activity, and walking and moderate-to-vigorous physical activity (MVPA)). The cutoff point of 7 h was
chosen for the amount of sleep according to National Sleep Foundation’s recommendation of sleep
duration for young adult and adult groups and older adults group [22]. MVPA included vigorous
intensity, moderate intensity, and strength-related physical activities.
2.2.4. Statistical Analysis
The general characteristics of the study participants were analyzed using analysis of variance
(ANOVA). The 10-year ASCVD risk score values were log-transformed for parametric tests. A multiple
regression analysis was used to analyze the associations between the blood heavy metal levels and
10-year ASCVD risk score. In addition, as blood heavy metal (Cd, Pb, Hg) levels were divided into
quartiles, the linear trend of the variables was evaluated. All our data were stratified by sex to
determine whether differences existed between men and women. SAS software, version 9.4 (SAS
Institute, Cary, NC, USA) was used for statistical analyses. All p-values were two-sided and were
considered significant when p < 0.05.
3. Results
3.1. General Characteristics
General characteristics of the study population are shown in Table 1; the relationships between the
KRPM 10-year ASCVD risk score and variables including blood heavy metal levels (Cd, Pb, Hg), age,
income status, job type, area of living, sleep duration, and physical activity type are shown stratified
according to sex. The 993 male participants had a relatively higher mean 10-year ASCVD risk score
of 11.19% (SD 9.99) than the 1,431 female participants, who had a mean risk score of 5.49% (SD 6.10).
In men, the following relationships were observed: for blood Cd and Pb levels, there was an observed
increase 10-year ASCVD risk score mean with statistically significant difference in mean between
quartiles (ANOVA Cd p < 0.0001, Pb p = 0.0008). The 1431 women showed results similar to that in the
men as follows: Blood Cd levels having an observed increase in 10-year ASCVD risk score mean with
statistically significant difference in mean between quartiles (ANOVA p < 0.0001). Blood Pb levels had
a general increasing observed increase, except for the 75% quartile of blood Pb level which did not fit
the observed increase of 10-year ASCVD risk score mean, but still having significant statistical mean
difference among quartiles (ANOVA p-value < 0.0001). For both sex, blood Hg levels did not show a
noticeable increasing observed increase but there was a significant statistical mean difference (ANOVA
men p < 0.0001, women p = 0.0387). The 2013 ACC/AHA 10-year ASCVD risk score showed little to no
difference in the general characteristics of the study population (Supplementary Table S1).
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3.2. Association between 10-Year ASCVD Risk Score and Blood Heavy Metal Quartiles
Table 2 shows the linear relationship between the log-adjusted 10-year ASCVD risk score and
blood heavy metal quartiles. There was a linear increase for all the three blood heavy metal levels
for men: blood Cd (p < 0.0001), Pb (p = 0.0097), and Hg (p = 0.0096) levels showed a linear trend of
statistical significance among men. Among women, there was a linear trend for all three heavy metals:
Blood Cd (p = 0.0024), Pb (p = 0.0330), Hg (p = 0.0030) levels.
When adjusting for age for multivariate linear regression, job type, area of living, sleep duration,
and physical activity, and when comparing the 25% quartile as the reference, Cd’s 50%, 75%, and
100% quartile, Pb’s 100% quartile, and Hg’s 100% quartile had significant statistical meaning for males.
Among females, only the 100% quartile for blood Cd levels (b = 0.102 p = 0.010) and 100% quartile
for Hg levels (b = 0.112 p = 0.005) had significant statistical meaning compared to the 25% quartile as
reference. All regression analyses were adjusted for age, income status, job type, area of living, sleep
duration, and physical activity type per week. There was a difference shown in the Supplementary
Table S2 with the original 10-year ASCVD risk that statistically significant linear trend did not appear
among Pb for men but others were almost identical.
3.3. Subgroup Analysis with Location of Residence and Sleep Duration
Subgroup analyses of the relationship between blood heavy metal quartiles and log-transformed
KRPM 10-year ASCVD risk scores by location of residence and sleep duration are shown in Table 3. The
urban population exhibited a stronger relationship between 10-year ASCVD risk score and blood heavy
metal levels, with Cd and Hg showing significant results especially for men. The rural population
showed minor statistically significant numbers. Subgroups by sleep duration showed fewer interesting
results in that both less than 7 h and more than 7 h groups did not differ except for the male Cd group
50% quartile, female Pb 100% quartile, and female Hg 100% quartile of under 7 h of sleep showing
significant results. As shown in Supplementary Table S3, the 2013 ACC/AHA 10-year ASCVD risk
score subgroup analysis had minor differences from the KRPM subgroup analysis.
4. Discussion
Blood heavy metal levels are possible influencing factors for cardiovascular diseases, including
ASCVD [23–25]. The results of this study support this concept by indicating a positive overall trend
between blood heavy metal levels (Cd, Pb, Hg) and 10-year ASCVD risk score in the Korean population
when adjusted for age, income status, job type, area of living, sleep duration, and physical activity.
Specifically, among the three xenobiotic metal levels observed, blood cadmium levels noticeably
increased the 10-year ASCVD risk score.
This result is in line with those of previous studies showing that high levels of blood xenobiotic
metals (Cd, Pb, Hg) led to increased risk of cardiovascular diseases such as coronal and peripheral
arterial disease [26,27], atherosclerosis [28–30], and hypertension [11,31]. Our findings extend this
concept to cardiovascular disease of atherosclerosis origin. To our knowledge, no other studies
suggested the relationship between blood heavy metal levels (Cd, Pb, Hg) and 10-year ASCVD risk
score directly. Our findings suggest that ASCVD risk rises with increases in blood heavy metal levels
(Cd, Pb, Hg).
Possible mechanisms have been proposed by earlier studies showing that cadmium acts as an
endocrine system disrupter by interacting with various hormonal pathways, often binding to estrogen
receptors, mimicking estrogen [32]. Cadmium also increases the formation of oxygen species and
binding to metallothionein, thereby interrupting anti-oxidative stress responses [33]. Lead has been
shown to increase the production of reactive oxygen species and oxidative tissue damage [34]. Mercury
causes oxidative stress by interacting with selenium [35], in addition to its role in inflammation [36].
Many other mechanisms have been suggested; however, no conclusive mechanism has been identified
for this linkage between blood heavy metal levels and ASCVD risk.
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One particular focus of this study was the difference of area of residence because cadmium, lead,
and mercury are known to be vehicular traffic-related heavy metals [37,38]. Our results indicated that
urban populations showed a stronger link between blood heavy metal levels and 10-year ASCVD risk
score, whereas rural populations showed no significant associations mainly among men. This result
along with possible mechanisms mentioned earlier suggest that area of living influences ASCVD risk,
likely because of its relationship with blood heavy metal levels.
Our findings have important real-world implications. It is crucial to reduce heavy metal exposure
so as to prevent increase in the incidence of ASCVD. ASCVD is a set of preventable diseases caused
by modifiable risk factors [39]. It is important to identify these modifiable risk factors and to take
preventive measures to decrease this incidence. Blood heavy metal levels (Cd, Pb, Hg) showed a
positive trend when analyzed with 10-year ASCVD risk score in the current study; these factors have
been recognized as influencing determinants for other cardiovascular diseases. These data suggest
that means to decrease the extent of heavy metal exposures need to be considered to further reduce
ASCVD occurrence.
There were some limitations to this study. First, the number of subjects in each subgroup was
relatively small. Subgroup analysis with the variables of sleep duration and area of living was
performed in the current study, but with a somewhat small number of subjects in each group. There is
potential for unintentional bias because of the relatively small number of subjects. Next, covariates
were carefully selected to minimize the risk of unexpected errors; however, other possible variables
might have influenced the outcome, resulting in unintentional bias. Moreover, the study featured a
cross-sectional design, the data is recorded only once for each individual, making it difficult to infer
the temporal association between blood heavy metal levels and ASCVD occurrence. In other words,
the results could not identify a definite causal relationship and rule out potential bidirectional effects.
Lastly, there is a risk of bias due to the complex multi-stage sampling, sub-sampling methods, and
missing data.
In conclusion, blood heavy metal levels (Cd, Pb, Hg) showed an overall positive trend with
10-year ASCVD risk score in the Korean population. The urban population had a stronger linkage
between blood Cd, Pb, and Hg levels and 10-year ASCVD risk scores. These findings suggest that
blood Cd, Pb, and Hg levels are potential influencing factors for ASCVD and suggest that these blood
metal levels should be considered in the prevention of ASCVD.
Supplementary Materials: The following are available online at http://www.mdpi.com/1660-4601/17/6/2134/s1,
Table S1. General characteristics of the study population at the 2016-2017 baseline. Table S2. Results of analyzing
the effect of the blood heavy metal quartile. Table S3. Subgroup analysis of the effect of the blood heavy
metal quartile.
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